These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7105593

  • 1. [Two cases of Parkinson's disease with diphasic dyskinesia, seen during levodopa treatment (author's transl)].
    Mano Y, Ando K, Muramoto O, Riku S.
    Rinsho Shinkeigaku; 1982 Mar; 22(3):209-15. PubMed ID: 7105593
    [No Abstract] [Full Text] [Related]

  • 2. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC, Vassallo M, Ross IN.
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract] [Full Text] [Related]

  • 3. Ocular dyskinesias in patients with Parkinson's disease treated with levodopa.
    Shimizu N, Cohen B, Bala SP, Mendoza M, Yahr MD.
    Ann Neurol; 1977 Feb; 1(2):167-71. PubMed ID: 889300
    [No Abstract] [Full Text] [Related]

  • 4. Blink reflex in Parkinson's disease with levodopa-induced dyskinesia.
    Iriarte LM, Chacon J, Madrazo J, Chaparro P.
    Funct Neurol; 1989 Feb; 4(3):257-61. PubMed ID: 2792861
    [Abstract] [Full Text] [Related]

  • 5. Serpentine tongue: A rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease.
    Prashantha DK, Pal PK.
    Parkinsonism Relat Disord; 2009 Nov; 15(9):718-9. PubMed ID: 19157953
    [No Abstract] [Full Text] [Related]

  • 6. Isoniazid therapy in Parkinson's disease.
    Gershanik OS, Luquin MR, Scipioni O, Obeso JA.
    Mov Disord; 1988 Nov; 3(2):133-9. PubMed ID: 3221901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ropinirole as compared with levodopa in Parkinson's disease.
    Frucht S.
    N Engl J Med; 2000 Sep 21; 343(12):885. PubMed ID: 11001686
    [No Abstract] [Full Text] [Related]

  • 10. Ropinirole as compared with levodopa in Parkinson's disease.
    Yamamoto T.
    N Engl J Med; 2000 Sep 21; 343(12):884; author reply 885. PubMed ID: 11001685
    [No Abstract] [Full Text] [Related]

  • 11. [Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time].
    Giménez-Roldán S, Mateo D, Gil Núñez A.
    Rev Clin Esp; 1980 Dec 31; 159(6):403-7. PubMed ID: 7221107
    [No Abstract] [Full Text] [Related]

  • 12. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M, Reichmann H, Riederer P.
    Mov Disord; 2005 May 31; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract] [Full Text] [Related]

  • 13. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE.
    Mov Disord; 2005 Mar 31; 20(3):342-4. PubMed ID: 15580606
    [Abstract] [Full Text] [Related]

  • 14. [A clinical analysis of L-dopa induced dyskinesia treated by posteroventral pallidotomy for Parkinson's disease].
    Zhao G, Li Y, Shao M, Ding Y.
    Zhonghua Wai Ke Za Zhi; 1999 Aug 31; 37(8):482-4. PubMed ID: 11829894
    [Abstract] [Full Text] [Related]

  • 15. The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.
    Tousi B, Subramanian T.
    Parkinsonism Relat Disord; 2005 Aug 31; 11(5):333-4. PubMed ID: 15949966
    [No Abstract] [Full Text] [Related]

  • 16. Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease.
    Rice JE, Antic R, Thompson PD.
    Mov Disord; 2002 May 31; 17(3):524-7. PubMed ID: 12112201
    [Abstract] [Full Text] [Related]

  • 17. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
    Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y.
    Ann Neurol; 2000 May 31; 47(5):655-8. PubMed ID: 10805339
    [Abstract] [Full Text] [Related]

  • 18. Rating scales for dyskinesias in Parkinson's disease.
    Goetz CG.
    Mov Disord; 1999 May 31; 14 Suppl 1():48-53. PubMed ID: 10493403
    [No Abstract] [Full Text] [Related]

  • 19. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.
    Mov Disord; 2005 Sep 31; 20(9):1205-9. PubMed ID: 15954135
    [Abstract] [Full Text] [Related]

  • 20. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
    Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, Håkansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, Bloch B, Bezard E.
    Parkinsonism Relat Disord; 2005 Jun 31; 11 Suppl 1():S25-9. PubMed ID: 15885624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.